Activplant, a provider of enterprise manufacturing intelligence solutions, has announced that GlaxoSmithKline has signed a global framework agreement naming Activplant as a recommended business intelligence solution for its worldwide manufacturing sites.
Subscribe to our email newsletter
The agreement comes after a successful implementation where GlaxoSmithKline (GSK) experienced the ease of use that empowers operators, engineers and management to positively affect their overall equipment effectiveness (OEE), and consequently, their production costs.
Activplant’s Throughput Analyzer software product is currently implemented within key GSK facilities in North America and the UK.
Julian Ward, application champion of GSK, said: “Once we saw how quickly Activplant’s Throughput Analyzer could be implemented and drive results in our facility in North Carolina, we felt that it made sense to negotiate a global framework agreement to reduce complexity where our facilities wish to consider implementing OEE projects.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.